* ContraFect Corp CFRX.OQ CFRX.O is expected to show a no
change in quarterly revenue when it reports results on August 12
(estimated).
* Refinitiv's mean analyst estimate for ContraFect Corp is for
a loss of 28 cents per share. For the same quarter last year,
the company reported a loss of 88 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for ContraFect Corp
is $14, about 71.2% above its last closing price of $4.03.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.22 -0.22 -0.18 Beat 18.2
Dec. 31 2020 -0.27 -0.31 -0.23 Beat 24.8
Sep. 30 2020 -0.34 -0.38 0.12 Beat 131.4
Jun. 30 2020 -0.34 -0.37 -0.88 Missed -139.1
Mar. -0.64 -0.62 -0.49 Beat 21
31 2020
Dec. 31 2019 -0.65 -0.83 -1.11 Missed -33.7
Sep. 30 2019 -0.75 -0.77 -0.70 Beat 9.7
Jun. 30 2019 -0.85 -0.86 -1.10 Missed -27.9
This summary was machine generated August 10 at 13:15 GMT. All
figures in US dollars unless otherwise stated